Trial NCT03444753

View at ClinicalTrials.gov 
Org. Study IDs: CA039-001

Last trial update was posted on 2022-05-23

MeSH Interventions

Ipilimumab Nivolumab

MeSH Conditions


Other Conditions

Advanced Cancer

Stopping Reasons

business objectives have changed

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID